Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144035 |
| CAS No | NA |
| Mol.F. | C16H18FN5O4 |
| Mol.Wt. | 363.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144036 |
| CAS No | NA |
| Mol.F. | C19H23FN6O4 |
| Mol.Wt. | 418.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144037 |
| CAS No | NA |
| Mol.F. | C20H22FN7O7 |
| Mol.Wt. | 491.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144038 |
| CAS No | NA |
| Mol.F. | C18H18FN5O7 |
| Mol.Wt. | 435.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144039 |
| CAS No | NA |
| Mol.F. | C20H21N7O6 |
| Mol.Wt. | 455.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144040 |
| CAS No | NA |
| Mol.F. | C22H26FN7O7 |
| Mol.Wt. | 519.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144041 |
| CAS No | NA |
| Mol.F. | C34H35F2N9O9 |
| Mol.Wt. | 751.70 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144042 |
| CAS No | NA |
| Mol.F. | C9H7FN2O4 |
| Mol.Wt. | 226.16 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144043 |
| CAS No | NA |
| Mol.F. | C22H26FN7O7 |
| Mol.Wt. | 519.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144044 |
| CAS No | NA |
| Mol.F. | C18H19FN6O6 |
| Mol.Wt. | 434.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144045 |
| CAS No | NA |
| Mol.F. | C17H18FN5O5 |
| Mol.Wt. | 391.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144046 |
| CAS No | NA |
| Mol.F. | C20H22FN7O7 |
| Mol.Wt. | 491.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144047 |
| CAS No | NA |
| Mol.F. | C20H22FN5O7 |
| Mol.Wt. | 463.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144048 |
| CAS No | NA |
| Mol.F. | C16H15FN4O4 |
| Mol.Wt. | 346.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144049 |
| CAS No | NA |
| Mol.F. | C20H20FN7O6 |
| Mol.Wt. | 473.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144050 |
| CAS No | NA |
| Mol.F. | C8H10N4O5 |
| Mol.Wt. | 242.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |